MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Inventories, Raw Materials & Components: ₺312 Mil (As of Mar. 2026)


IST:MEDTR MEDITERA TIBBI MALZEME SANAYI VE TICARET AS IST:MEDTR
82 GF Score
Price ₺28.86
GF Value ₺43.61
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS Inventories, Raw Materials & Components?

MEDITERA TIBBI MALZEMENAYI VE TICARET AS IST:MEDTR -1.30% 82 Inventories, Raw Materials & Components is ₺312 Mil as of Mar. 2026. GuruFocus rates IST:MEDTR with a GF Score™ of 82/100 and a GF Value™ of ₺43.61 (Significantly Undervalued). The stock has 5 warning signs investors should review.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₺312 Mil.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's quarterly raw materials declined from Sep. 2025 (₺348 Mil) to Dec. 2025 (₺285 Mil) but then increased from Dec. 2025 (₺285 Mil) to Mar. 2026 (₺312 Mil).

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's annual raw materials increased from Dec. 2023 (₺223 Mil) to Dec. 2024 (₺387 Mil) but then declined from Dec. 2024 (₺387 Mil) to Dec. 2025 (₺285 Mil).

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Inventories, Raw Materials & Components Chart

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 33.18 151.69 223.24 386.57 284.69

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 328.38 348.59 347.65 284.69 311.72
IST:MEDTR
82GF Score
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS IST:MEDTR
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₺312 Mil mean?
MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) has a Inventories, Raw Materials & Components of ₺312 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Inventories, Raw Materials & Components too high?
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Inventories, Raw Materials & Components is ₺312 Mil. Overall, MEDITERA TIBBI MALZEMENAYI VE TICARET AS has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Inventories, Raw Materials & Components compare to ABT and SYK?
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Inventories, Raw Materials & Components of ₺312 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Inventories, Raw Materials & Components is ₺312 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock overvalued right now?
Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) is currently considered Significantly Undervalued. The stock's GF Value™ is ₺43.61, compared to a current price of ₺28.86 — trading 33.8% below its estimated fair value. The current Inventories, Raw Materials & Components is ₺312 Mil. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR), the current Inventories, Raw Materials & Components is ₺312 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Overvalued in 2026?

Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock appears to be undervalued. The current stock price of ₺28.86 is trading 33.8% below its estimated GF Value™ of ₺43.61. GuruFocus considers MEDITERA TIBBI MALZEMENAYI VE TICARET AS to be Significantly Undervalued.

Key valuation signals for IST:MEDTR:

  • Inventories, Raw Materials & Components: ₺312 Mil
  • GF Value™: ₺43.61 vs. price of ₺28.86 (33.8% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the IST:MEDTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description

Address Sokak No: 29 Tire Organize Sanayi, Ibni Melek OSB Mahallesi, TOSBI Yol 4, Bolgesi Tire, Izmir, TUR, 35900
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.
82GF Score

Get the complete analysis for IST:MEDTR

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺28.86
Price
₺43.61
GF Value